Peroxisomal ABC Transporters: An Update
Open accessThe DOI matches its Crossref record; 176 of the 178 references it cites were found in a registry or an index; 9 of the 213 sources its claims cite were checked for support.
Abstract
ATP-binding cassette (ABC) transporters constitute one of the largest superfamilies of conserved proteins from bacteria to mammals. In humans, three members of this family are expressed in the peroxisomal membrane and belong to the subfamily D: ABCD1 (ALDP), ABCD2 (ALDRP), and ABCD3 (PMP70). These half-transporters must dimerize to form a functional transporter, but they are thought to exist primarily as tetramers. They possess overlapping but specific substrate specificity, allowing the transport of various lipids into the peroxisomal matrix. The defects of ABCD1 and ABCD3 are responsible for two genetic disorders called X-linked adrenoleukodystrophy and congenital bile acid synthesis defect 5, respectively. In addition to their role in peroxisome metabolism, it has recently been proposed that peroxisomal ABC transporters participate in cell signaling and cell control, particularly in cancer. This review presents an overview of the knowledge on the structure, function, and mechanisms involving these proteins and their link to pathologies. We summarize the different in vitro and in vivo models existing across the species to study peroxisomal ABC transporters and the consequences of their defects. Finally, an overview of the known and possible interactome involving these proteins, which reveal putative and unexpected new functions, is shown and discussed.
Overview
CoChat Summary
## TL;DR
This is a narrative review of peroxisomal ABC transporters, focusing on ABCD1, ABCD2, and ABCD3, and how their structure, transport mechanism, interacting partners, and disease links shape lipid metabolism and cell signaling. It highlights that these transporters are central not only to β-oxidation of fatty acids but also to X-linked adrenoleukodystrophy, congenital bile acid synthesis defect type 5, cancer-associated expression changes, and peroxisome-organelle communication.
## Key findings
- Human peroxisomal ABC transporters ABCD1, ABCD2, and ABCD3 are half-transporters that must dimerize; the paper states ABCD1 and ABCD3 are mainly found as homodimers, while ABCD1/ABCD2 heterodimers and tetramers also occur.
- Substrate specificity differs across transporters: ABCD1 transports saturated and monounsaturated VLCFAs; ABCD2 overlaps with ABCD1 but is also linked to PUFA transport, especially DHA and its precursor C24:6 n-3; ABCD3 has the broadest specificity, including LCFAs, VLCFAs, dicarboxylic acids, branched-chain fatty acids, and C27 bile acid intermediates.
- The paper states X-linked adrenoleukodystrophy has an estimated incidence of 1:17,000, and ABCD1 mutations are found in every X-ALD patient; nearly 900 non-recurrent mutations are noted, but no genotype-phenotype correlation has been described.
- In X-ALD, Abcd1 knockout mice reproduce the biochemical phenotype, and a prospective phase II pilot study in 13 AMN patients treated with antioxidant molecules reportedly normalized biomarkers of oxidative damage and inflammation and improved locomotion.
## Methods
- Not stated in the paper.
- The article is a literature review that synthesizes prior structural, biochemical, genetic, animal-model, cell-model, proteomic, and clinical studies on peroxisomal ABC transporters.
- Its evidence base includes functional complementation assays, knock-out and transgenic animal models, co-immunoprecipitation/proteomics, yeast and plant models, patient fibroblasts, and cited clinical studies.
## Limitations
- The paper explicitly notes that exact substrate specificity and the functional relevance of some dimeric/oligomeric states remain unclear, and that the exact transport mechanism remains controversial.
- It states that no model exactly mimics human X-ALD.
- Evident from the text: because this is a review, it does not present a new primary dataset or a unified quantitative meta-analysis of the cited studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Structural model of human ABCD1 (reprinted from [17]). (A) Ribbon representation of the ABCD1 monomer. TMD helices are numbered from 1 to 6 and rainbow colored from dark blue to red. NBD is in light grey, and intracellular loops (ICL) 1 and 2 are indicated. (B) Ribbon representation of the ABCD1 homodimer with the two subunits respectively colored in dark blue and yellow.](https://figures.cochat.ai/paper-figures/d9b6132383424bcbbf06be774b3e354d/peroxisomal-abc-transporters-an-update-figure-2.jpg)
Verification
Claims the paper makes
7 Valid · 3 Not valid · 135 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Using transgenic expression of Abcd2 in the Abcd1 knock-out mouse, Pujol et al. demonstrated that VLCFA accumulation and disease phenotype could be corrected in vivo [ 40 ].”
What the sources say
- Supportedcites [40] Pujol, 2004, Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: A therapeutic target for X-adrenoleukodystrophy, Hum. Mol. Genet. source
The Results section reports that ALDR overexpression in ALD-deficient mice normalized VLCFA levels in all organs analyzed. The Discussion reports long-term prevention of the neurodegenerative features caused by ALD loss, supporting the claim of an in vivo disease-phenotype rescue. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Oxidative stress and cellular components, especially microglial functions, seem to play a major role in the pathogenesis of X-ALD [ 89 , 90 , 91 ].”
What the sources say
- Not checked yetcites [89] Singh, 2010, Pathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis, Brain Pathol. source
- Not checked yetcites [90] Bergner, 2019, Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy, Glia source
- Partly supportedcites [91] Gong, 2017, Microglial dysfunction as a key pathological change in adrenomyeloneuropathy, Ann. Neurol. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) links altered microglial function to neuronal damage in adrenomyeloneuropathy (AMN) and says oxidative stress may prime phagocytosis. But the study focuses on AMN rather than establishing these roles across X-ALD, and it says the contribution of other cell types was beyond its scope. (LLM, conf=0.84)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Abcd1/Abcd2 double knock-out mice have an earlier and more severe neurological phenotype associated with inflammatory T lymphocyte infiltration in the spinal cord [ 40 ]”
What the sources say
- Supportedcites [40] Pujol, 2004, Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: A therapeutic target for X-adrenoleukodystrophy, Hum. Mol. Genet. source
The DISCUSSION of our copy states that in double knockouts 'the AMNlike pathology is more severe with an earlier onset (12 months rather than 20 months in the ALD KO)' and that they 'present inflammatory infiltrates in the spinal cord composed mainly of T lymphocytes, pathological features that are not present in single ALD or ALDR mutants.' The Spinal cord histopathology section corroborates the T-lymphocyte perivascular/perimeningeal infiltrates in double mutants only, and the neurological phenotype section reports considerably worsened rotarod performance with severe impairment already at 15 months versus 20 months in ALD-/- mice. All elements of the claim (earlier, more severe, spinal cord T-cell infiltrates) are stated. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Pharmacological induction of ABCD2 was indeed shown to compensate for ABCD1 defect in vitro and in rare cases, in vivo, opening the way for clinical trials [ 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ].”
What the sources say
- Not checked yetcites [43] Kemp, 1998, Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy, Nat. Med. source
- Partly supportedcites [44] Weber, F.D., Weinhofer, I., Einwich, A., Forss-Petter, S., Muneer, Z., Maier, H., Weber, W.H., and Berger, J. (2014). Evaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy. PLoS ONE, 9. sourceExperimental — accuracy not yet measured
The Introduction (p. n/a) states that 'Upon overexpression, ABCD2 is able to restore VLCFA metabolism both in vitro and in vivo' and that 'induction of ABCD2 gene expression by pharmacological means has been proposed as an alternative treatment option for X-ALD' — so the compensation concept and the pharmacological-induction rationale are in our copy, but the in vitro/in vivo restoration is attributed to genetic overexpression (refs [12],[13]), not to pharmacological induction. Our copy does not support the claim's 'in rare cases in vivo' for pharmacological induction; on the contrary, the Results section 'Evaluation of the ability of 13CRA to induce ABCD2 mRNA in human primary monocytes in vivo' (Fig. 3) reports that ABCD2 mRNA was unchanged in monocytes, B cells and T-cell-enriched PBMCs of 13CRA-treated acne patients, and the Discussion concludes that 'retinoids are probably not able to induce ABCD2 to a level high enough for a compensation of ABCD1 deficiency in macrophages in vivo'. (LLM, conf=0.75)
- Not checked yetcites [45] Rampler, 2003, Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy, Mol. Genet. Metab. source
- Not checked yetcites [46] Fourcade, 2001, Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2)—Promoter analysis and role of the peroxisome proliferator-activated receptor PPAR alpha, Eur. J. Biochem. source
- Not checked yetcites [47] Fourcade, 2003, Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2), Mol. Pharmacol. source
- Not checked yetcites [48] Gondcaille, 2005, Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator, J. Cell Biol. source
- Not checked yetcites [49] Leclercq, 2008, Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters, Biochimie source
- Not checked yetcites [50] Genin, 2009, Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics, J. Steroid Biochem. Mol. Biol. source
- Not checked yetcites [51] Gondcaille, 2014, LXR antagonists induce ABCD2 expression, Biochim. Biophys. Acta source
- Not checked yetcites [52] Trompier, 2014, Regulation of the adrenoleukodystrophy-related gene (ABCD2): Focus on oxysterols and LXR antagonists, Biochem. Biophys. Res. Commun. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“These promising results suggest that such a therapeutic strategy may be as effective as allogeneic HSCT.”
What the sources say
- Supportedcites [82] Cartier, 2009, Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy, Science source
In the section on ex vivo lentiviral-mediated ABCD1 transfer, the paper says the neurologic benefits of HSC gene therapy in ALD were comparable to those seen with allogeneic HCT. Its finding in two patients supports the citing sentence’s cautious suggestion that the strategy may be as effective. (LLM, conf=0.91)
- Not checked yetcites [83] Eichler, 2017, Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy, N. Engl. J. Med. source
hedgedstates a possible causen = 15- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
69 more claims
Create a free account to see all 173 claims and to verify the 204 references still open.
- It may state two separate claims as one. 82
- Probably not a substantial claim. 29
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Very-long-chain fatty acid import into peroxisomes is mediated by the ABC transporters ABCD1 and ABCD2, which have overlapping but distinct substrate preferences (Tawbeh et al., 2021) (Figure 1).”
From The neurological pathology of peroxisomal ACBD5 deficiency – lessons from patients and mouse models (2025) · cites this paper as Tawbeh et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“PEX19p is the only ABCD2 binding partner that has been reported in the literature”
“Data shows that ABCD1, ABCD2, and ABCD3 are able to interact as homodimers or heterodimers [ 20 , 21 , 22 ]”
Citations
Cites
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 3×
“Recent therapeutic successes [82,83], and the feasibility and reliability of a diagnosis method based on VLCFA quantification from blood spot [84,85], have prompted some countries to establish systematic screening of newborns.”
BackgroundArchitecture of the human interactome defines protein communities and disease networks
Huttlin, E. L., Bruckner, R. J., Paulo, J. A., Cannon, J. R., Ting, L., Baltier, K., Colby, G., Gebreab, F., Gygi, M. P., Parzen, H., et al. (2017) · Nature · doi:10.1038/nature22366 · Cited by 1,437
The BioPlex network: a systematic exploration of the human interactome
Huttlin, E. L., Ting, L., Bruckner, R. J., Gebreab, F., Gygi, M. P., Szpyt, J., Tam, S., Zarraga, G., Colby, G., Baltier, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.043 · Cited by 1,425
A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
Hein, M. Y., Hubner, N. C., Poser, I., Cox, J., Nagaraj, N., Toyoda, Y., Gak, I. A., Weisswange, I., Mansfeld, J., Buchholz, F., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.053 · Cited by 1,270
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202 · cited 2×
“In 1993, using positional cloning, the team of Hugo Moser identified the ABCD1 gene as being responsible for X-ALD [30].”
BackgroundMethodBiochemistry of mammalian peroxisomes revisited
Wanders, R. J. A., & Waterham, H. R. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133329 · Cited by 995 · cited 3×
“β-oxidation of FAs is a conserved process of peroxisomes by which acyl groups are degraded two carbons at a time after being activated to form the corresponding CoA derivative by a specific acyl-CoA synthetase located at the peroxisomal membrane [7].”
BackgroundLarge‐scale mapping of human protein–protein interactions by mass spectrometry
Ewing, R. M., Chu, P., Elisma, F., Li, H., Taylor, P., Climie, S., McBroom‐Cerajewski, L., Robinson, M. D., O'Connor, L., Li, M., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100134 · Cited by 984
Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 959
A Census of Human Soluble Protein Complexes
Havugimana, P. C., Hart, G. T., Nepusz, T., Yang, H., Turinsky, A. L., Li, Z., Wang, P. I., Boutz, D. R., Fong, V., Phanse, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.011 · Cited by 860
Efficient derivation of microglia-like cells from human pluripotent stem cells
Muffat, J., Li, Y., Yuan, B., Mitalipova, M., Omer, A., Corcoran, S., Bakiasi, G., Tsai, L.-H., Aubourg, P., Ransohoff, R. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4189 · Cited by 651
Research works printed but not linked: 1
- Hebron, 2000, Defective phytanic and pristanic acids metabolism in PMP70 deficient mice results in defective nonshivering thermogenesis and dicarboxylic aciduria, J. Inherit. Metab. Dis., 23, 256
Cited by
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
Lepiarz-Raba, I., Gbadamosi, I., Florea, R., Paolicelli, R. C., & Jawaid, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00382-w · Cited by 90
Expression and Function of ABC Proteins in Fish Intestine
Bieczynski, F., Painefilú, J. C., Venturino, A., & Luquet, C. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.791834 · Cited by 60
The Physiological and Pathological Role of Acyl-CoA Oxidation
Szrok-Jurga, S., Czumaj, A., Turyn, J., Hebanowska, A., Świerczyński, J., Śledziński, T., & Stelmańska, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914857 · Cited by 62
“Three of these, ABCD1-3, are localized solely in peroxisomes and mediate the uptake of substrates into the peroxisome for βOX [115].”
BackgroundChen, Z.-P., Xu, D., Wang, L., Mao, Y.-X., Li, Y., Cheng, M.-T., Zhou, C.-Z., Hou, W.-T., & Chen, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-30974-5 · Cited by 37
Ghzaiel, I., Zarrouk, A., Nury, T., Libergoli, M., Florio, F., Hammouda, S., Ménétrier, F., Avoscan, L., Yammine, A., Samadi, M. H., et al. (2021) · Antioxidants · doi:10.3390/antiox10111772 · Cited by 44
“Abcd3 (ATP binding cassette subfamily D member) is a major component of the peroxisomal membrane and a common constituent of peroxisomes in different tissues [91,92] (Supplementary Figure S9).”
Background
Metadata
- Authors
- Tawbeh, A., Gondcaille, C., Trompier, D., & Savary, S.
- Affiliations
- Université de Bourgogne (FR)
- Corresponding author
- Savary, Stéphane
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-05
- Volume
- 22
- Issue
- 11
- Pages
- 6093
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8201181
- OpenAlex
- W3167214555
- Cited by
- 68
- References
- 178
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 17 · 2023: 13 · 2022: 10 · 2021: 2
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- peroxisomal ABC transporters, ABCD1, ABCD2, ABCD3, peroxisomal membrane, X-linked adrenoleukodystrophy, protein dimerization, protein-protein interaction network, cancer
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, ATP Binding Cassette Transporter, Subfamily D, Member 1, Adrenoleukodystrophy, Cholestasis, Fatty Acids, Humans, ATP-Binding Cassette Transporters, Peroxisomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peroxisomal ABC Transporters: An Update. https://app.cochat.ai/papers/10.3390/ijms22116093
- The paper
- Tawbeh, A., Gondcaille, C., Trompier, D., & Savary, S. (2021). Peroxisomal ABC Transporters: An Update. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22116093
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.